Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

D-Pharm Climbs Most in Two Weeks on Deal to Acquire Thrombotech

Don't Miss Out —
Follow us on:

May 7 (Bloomberg) -- D-Pharm Ltd. rose the most in more than two weeks after the biopharmaceutical company reached an initial agreement to buy Thrombotech Ltd., which is developing a peptide that improves the efficiency of stroke medication.

The shares of the Nes Ziona, Israel-based company rose 8 percent, the biggest intraday advance since April 19, to 1.011 shekels at 3:11 p.m. in Tel Aviv.

To contact the reporter on this story: David Wainer in Tel Aviv at dwainer3@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.